We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.8B
AUM Growth
+$1.26B
Cap. Flow
+$567M
Cap. Flow %
3.2%
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$82.7M
2
PEP icon
PepsiCo
PEP
+$76.8M
3
MAR icon
Marriott International
MAR
+$64.8M
4
TSN icon
Tyson Foods
TSN
+$62.8M
5
PARA
Paramount Global Class B
PARA
+$52.9M

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$64.8M
2
HRL icon
Hormel Foods
HRL
+$61.4M
3
GILD icon
Gilead Sciences
GILD
+$59.9M
4
HLT icon
Hilton Worldwide
HLT
+$54.7M
5
FTI icon
TechnipFMC
FTI
+$51M

Sector Composition

Rank Sector Weight
1 Technology 14.87%
2 Healthcare 14.18%
3 Financials 11.71%
4 Industrials 10.79%
5 Consumer Discretionary 10.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTRE icon
2176
CareTrust REIT
CTRE
$10.2B
– –
-243
Closed -$3K
CTS icon
2177
CTS Corp
CTS
$1.72B
$0 ﹤0.01%
+53
New +$1K
CUBE icon
2178
CubeSmart
CUBE
$9.53B
$0 ﹤0.01%
3
-154
-98% -$4.41K
CVEO icon
2179
Civeo
CVEO
$379M
– –
-18
Closed –
CVI icon
2180
CVR Energy
CVI
$3.36B
$0 ﹤0.01%
41
– –
CVR icon
2181
Chicago Rivet & Machine Co
CVR
$9.56M
– –
-500
Closed -$13K
CYD icon
2182
China Yuchai International
CYD
$1.69B
$0 ﹤0.01%
113
– –
CYTK icon
2183
Cytokinetics
CYTK
$11B
$0 ﹤0.01%
+88
New +$919
DHT icon
2184
DHT Holdings
DHT
$2.97B
– –
-7,000
Closed -$35K
EDC icon
2185
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$147M
– –
-500
Closed -$25K
EFC
2186
Ellington Financial
EFC
$1.68B
$0 ﹤0.01%
64
– –
ENTA icon
2187
Enanta Pharmaceuticals
ENTA
$372M
– –
-1,000
Closed -$22K
ERIE icon
2188
Erie Indemnity
ERIE
$11.7B
– –
-20
Closed -$1K
ESPR
2189
DELISTED
Esperion Therapeutics
ESPR
– –
-500
Closed -$4K
EXAS
2190
DELISTED
Exact Sciences
EXAS
$0 ﹤0.01%
+45
New +$793
FFIC
2191
DELISTED
Flushing Financial
FFIC
– –
-46
Closed –
FIVE icon
2192
Five Below
FIVE
$11.2B
– –
-152
Closed -$7K
FIX icon
2193
Comfort Systems
FIX
$61B
– –
-16,187
Closed -$527K
FOR icon
2194
Forestar Group
FOR
$1.44B
$0 ﹤0.01%
+78
New +$942
FOSL icon
2195
Fossil Group
FOSL
$239M
$0 ﹤0.01%
24
– –
FRO icon
2196
Frontline
FRO
$8.75B
$0 ﹤0.01%
1
-31
-97% -$240
FRST icon
2197
Primis Financial Corp
FRST
$382M
– –
-276
Closed -$3K
FXF icon
2198
Invesco CurrencyShares Swiss Franc Trust
FXF
$409M
– –
-1,390
Closed -$136K
GAIN icon
2199
Gladstone Investment Corp
GAIN
$635M
$0 ﹤0.01%
147
– –
GALT icon
2200
Galectin Therapeutics
GALT
$229M
– –
-8,063
Closed -$11K
86 87
88
89 90

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q3 2016 Portfolio in Review

As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.

  • Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
  • Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
  • Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
  • Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
  • Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
  • Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
  • Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.

Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.